Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409 |
Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA |
Ref : Diabet Med , 27 :1409 , 2010 |
Abstract : Forst_2010_Diabet.Med_27_1409 |
ESTHER : Forst_2010_Diabet.Med_27_1409 |
PubMedSearch : Forst_2010_Diabet.Med_27_1409 |
PubMedID: 21059094 |
Forst T, Uhlig-Laske B, Ring A, Graefe-Mody U, Friedrich C, Herbach K, Woerle HJ, Dugi KA (2010)
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes
Diabet Med
27 :1409
Forst T, Uhlig-Laske B, Ring A, Graefe-Mody U, Friedrich C, Herbach K, Woerle HJ, Dugi KA (2010)
Diabet Med
27 :1409